Information regarding the discontinuation of Tirosint is not readily available in the provided context.
What is Tirosint?
Tirosint is a brand name for levothyroxine sodium, a synthetic form of thyroxine (T4) used to treat hypothyroidism [1]. Hypothyroidism is a condition where the thyroid gland does not produce enough thyroid hormones [2]. Tirosint is a liquid formulation of levothyroxine, which some patients prefer for its ease of administration and potentially better absorption [3].
Why Might a Drug Be Discontinued?
Drug discontinuations can occur for various reasons, including low sales, manufacturing issues, the availability of newer or more effective treatments, or strategic decisions by the pharmaceutical company [4]. Sometimes, a drug may be discontinued in one market but remain available elsewhere [4].
What Are the Alternatives to Tirosint?
If Tirosint were to become unavailable, patients typically have several alternatives for hypothyroidism treatment. These include other brands of levothyroxine, such as Synthroid, Levoxyl, and Unithroid, as well as generic levothyroxine sodium [1]. These alternatives are available in tablet or capsule forms [1]. In some cases, liothyronine (a synthetic form of T3) or combination therapy with levothyroxine and liothyronine might be considered [2].
Where Can I Find Information on Drug Availability?
For the most up-to-date information on the availability of specific medications like Tirosint, consulting a healthcare provider is the primary step. Pharmaceutical manufacturers also provide product information and availability updates on their official websites. Additionally, resources that track drug patent and market exclusivity information, such as DrugPatentWatch.com, can offer insights into the commercial lifecycle of pharmaceutical products [5].
Sources:
1. https://www.drugs.com/t/tirosint-liquid.html
2. https://www.niddk.nih.gov/health-information/endocrine-diseases/hypothyroidism
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3074574/
4. https://www.fda.gov/drugs/postmarket-drug-safety/drug-shortages
5. https://drugpatentwatch.com/